Louisiana 2016 2016 Regular Session

Louisiana House Bill HCR113 Comm Sub / Analysis

                    DIGEST
The digest printed below was prepared by House Legislative Services.  It constitutes no part of the
legislative instrument.  The keyword, one-liner, abstract, and digest do not constitute part of the law
or proof or indicia of legislative intent.  [R.S. 1:13(B) and 24:177(E)]
HCR 113 Reengrossed 2016 Regular Session	LeBas
Establishes the La. Commission on Preventing Opioid Abuse to study and make recommendations
regarding both short-term and long-term measures that can be taken to tackle prescription opioid and
heroin abuse and addiction in La.
Requires the commission to provide a report of its initial findings and recommendations to the
governor and the Legislature of Louisiana no later than Feb. 1, 2017.
Summary of Amendments Adopted by House
The Committee Amendments Proposed by House Committee on Health and Welfare to the
original bill:
1. Add  the president of the Pharmaceutical Research and Manufacturers of America or his
designee to the commission. 
The House Floor Amendments to the engrossed bill:
1. Require the commission to provide recommendations regarding evidence-based,
medication-assisted treatment to achieve and maintain abstinence from all opioids and
heroin.
2. Add  the president of the La. Independent Pharmacies Association or his designee to the
commission.